Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study

Overview of attention for article published in Journal of Asthma and Allergy, January 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 61 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,559 followers.

Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study https://t.co/6b31ATPOa6

14 Sep 2019

Reply Repost Favourite

Real-world characteristics and disease burden of patients with #asthma prior to treatment initiation with mepolizumab or omalizumab #lung #respiratory https://t.co/ZwUY5Bfx6I https://t.co/qv00rooRYo

23 Feb 2019

Reply Repost Favourite

Nasal Polyp Studies Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study. https://t.co/99e9gSWIro

19 Feb 2019

Reply Repost Favourite

In the 12 months, compared to asthmatics (aged≥12 years) prescribed #omalizumab, those taking #mepolizumab showed; ⬆️ #Exacerbations ⬆️ #Asthma-related HCRU for outpatient services ⬆️ Total asthma-related healthcare costs JAA | @DovePress https://t.co/

29 Jan 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.